COCCN(C(=O)CSc1nnc(-c2ccc(C(C)(C)C)cc2)n1N)c1c(N)n(CC(C)C)c(=O)[nH]c1=O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?